Helminth-induced Immunomodulation Therapy (HINT) in Relapsing-remitting Multiple Sclerosis

Clinical trial NCT00645749 · COMPLETED

Trial details

NCT number: NCT00645749
Sponsor: University of Wisconsin, Madison
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2008-07-01
Primary completion: 2015-08-13
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.